112 related articles for article (PubMed ID: 2714622)
1. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
[TBL] [Abstract][Full Text] [Related]
2. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
3. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
4. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
[TBL] [Abstract][Full Text] [Related]
6. Effects of several catecholamine-derived tetrahydroisoquinolines on the hypogastric nerve-vas deferens preparation of the rat.
Baird-Lambert J; Cohen G
J Pharm Pharmacol; 1975 Dec; 27(12):958-61. PubMed ID: 2673
[No Abstract] [Full Text] [Related]
7. Release of neuropeptide Y (NPY) induced by tyramine in the isolated vas deferens of rat.
Cheng JT; Shen CL
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):255-60. PubMed ID: 3108675
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
[TBL] [Abstract][Full Text] [Related]
10. No reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-benzyl-1,2,3,4-tetrahydroisoquinoline.
Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Sano T
Brain Res; 2003 Jan; 960(1-2):282-5. PubMed ID: 12505685
[TBL] [Abstract][Full Text] [Related]
11. [Tetrahydroisoquinoline and parkinsonism].
Yoshida M
Rinsho Shinkeigaku; 1989 Dec; 29(12):1501-3. PubMed ID: 2630145
[TBL] [Abstract][Full Text] [Related]
12. [Tetrahydroisoquinolines in connection with Parkinson's disease].
Ohta S
Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
[TBL] [Abstract][Full Text] [Related]
13. Effects of haloperidol on neurotransmitter activity in the rat vas deferens.
Miranda HF; Wolstenholme WW; Moreu GM; Santiago PA
Gen Pharmacol; 1988; 19(1):123-7. PubMed ID: 2894332
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment.
Keith RA; Salama AI
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):412-9. PubMed ID: 2885761
[TBL] [Abstract][Full Text] [Related]
15. Stereoselectivity of catecholamines: differential effects of cocaine and desipramine on catecholamine-induced contractions of the rat isolated vas deferens.
Park BK; Haynes BP; Sheridan SA; Nowell PT
J Pharm Pharmacol; 1983 Jun; 35(6):373-7. PubMed ID: 6135776
[TBL] [Abstract][Full Text] [Related]
16. The effect of ethacrynic acid on the guinea-pig and rat isolated vas deferens.
Khoyi MA; Pousti A; Zarrindast MR
Br J Pharmacol; 1974 Dec; 52(4):579-84. PubMed ID: 4455332
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness of the rat vas deferens to catecholamines and electrical stimulation during an infection with Trypanosoma brucei.
Adeboye OO; Oriowo MA
Afr J Med Med Sci; 1984; 13(3-4):135-8. PubMed ID: 6099973
[TBL] [Abstract][Full Text] [Related]
18. In vitro denervation of the rat vas deferens through hypothermic storage.
Jurkiewicz NH; Garcia AG; Jurkiewicz A
Br J Pharmacol; 1992 Oct; 107(2):610-5. PubMed ID: 1422602
[TBL] [Abstract][Full Text] [Related]
19. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
Tasaki Y; Makino Y; Ohta S; Hirobe M
J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
[TBL] [Abstract][Full Text] [Related]
20. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
Sallés J; Badia A
Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
